Baseline subtypes predict dementia and death in patients with Parkinson’s diseaseNovember 23, 2019Parkinson's Disease
Increased Parkinson’s disease risk seen with bipolar disorderOctober 14, 2019Parkinson's DiseaseMovement Disorders
FDA approves istradefylline for Parkinson’s diseaseAugust 28, 2019Parkinson's DiseaseMovement Disorders
Anticholinergic drugs linked to dementia in older populationsJune 24, 2019Alzheimer's & CognitionParkinson's DiseaseEpilepsy & SeizuresMovement Disorders
CSF neurofilament light level could aid in diagnosisJune 18, 2019Alzheimer's & CognitionMovement DisordersParkinson's DiseaseMultiple Sclerosis
Treatment for hepatitis C reduces risk of Parkinson’s diseaseJune 6, 2019Parkinson's DiseaseMovement Disorders
Appendectomy linked to increased risk of subsequent Parkinson’sMay 9, 2019Parkinson's DiseaseMovement Disorders
Physical activity slows cognitive decline in patients with Parkinson’s diseaseMay 7, 2019Parkinson's DiseaseNeuromuscular Disorders
Biomarkers in tears may help identify patients with Parkinson’s diseaseMay 6, 2019Parkinson's DiseaseMovement Disorders
Isradipine for Parkinson’s disease fails in phase 3 studyMay 2, 2019Parkinson's DiseaseMovement Disorders
Out-of-pocket costs for neurologic medications rise sharplyMay 1, 2019Alzheimer's & CognitionBusiness of MedicineParkinson's Disease
Opicapone increased on-time without dyskinesia in patients with Parkinson’s diseaseMay 1, 2019Parkinson's DiseaseMovement Disorders
Mindfulness yoga reduced stress and motor symptoms in patients with Parkinson’s diseaseApril 8, 2019Parkinson's Disease
Can intraputamenal infusions of GDNF treat Parkinson’s disease?March 25, 2019Parkinson's DiseaseMovement Disorders
